The most recent study conducted by Report Ocean, titled “Global Parkinson’s Disease Treatment Market Size, Share, Pricing, Trends, Growth, Report and Forecast 2023-2030,” presents a comprehensive analysis of the worldwide market. This research delves into the factors driving the market, emerging trends, opportunities for development, as well as potential limitations that may affect the Parkinson’s Disease Treatment. The report provides an estimation of the global market size and examines recent strategic actions taken by prominent international competitors.
Global Parkinson’s Disease Treatment Market Size study, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics), and Regional Forecasts 2022-2028Global Parkinson’s Disease Treatment Market is valued approximately USD $ Billion in 2021 and is anticipated to grow with a healthy growth rate of more than $ over the forecast period 2022-2028.
Request To Download Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=bw5126
According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.
Parkinson’s disease is a disorder of the central nervous system that damage the nerve cell in the brain, which causes dopamine levels to drop, and affects movement, often including tremors, rigidity, bradykinesia, and postural volatility as its common symptoms. The rising prevalence of Parkinson’s disease, the growing geriatric population, coupled with the increasing government funding for research and development activities are the primary factors that may surge the market demand across the globe.
For instance, according to the Parkinson’s Foundation, in the United States, in 2020, approximately one million people are suffering from Parkinson’s disease (PD) that is more than the total number of populations which is diagnosed with multiple sclerosis, muscular dystrophy, and Lou Gehrig’s disease (or Amyotrophic Lateral Sclerosis), and the amount is projected to reach 1.2 million individuals by the end of 2030. However, the availability of alternative treatments impedes the growth of the market over the forecast period of 2022-2028. Also, patent expiry of branded drugs and a strong drug pipeline are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Parkinson’s Disease Treatment market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of well-developed healthcare infrastructure, and increasing prevalence of the disorder. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising number of research and development activities, as well as supportive government policies would create lucrative growth prospects for the Parkinson’s Disease Treatment market across the Asia-Pacific region.
Download Free Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=bw5126
Major market players included in this report are:
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH.
Impax Laboratories LLC
AbbVie Inc.
Bausch Health.
Lundbeck
Sun Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc.
Merck & Co. Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Other Drugs
By Distribution Channel
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies
By Patient Care Setting
Hospitals
Clinics
Download Free Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=bw5126
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Russia-Ukraine War on Market
The market is anticipated to suffer because of the Russia-Ukraine War. The demand for the market has decreased as a result of the political unrest and economic unrest in the area. The war had a detrimental impact on global economic activity, adding to inflationary pressures globally and hindering the post-pandemic recovery, even if it was not the primary cause of the slower-than-anticipated economic growth in 2022 and revised estimates for 2023.
The Five Forces analysis examines the following factors:
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
The PESTLE analysis takes into account the following dimensions:
- Political factors: This includes political policies, stability, and factors related to trade, fiscal policies, and taxation policies.
- Economic factors: This involves analyzing interest rates, employment or unemployment rates, raw material costs, and foreign exchange rates.
- Social factors: These encompass changing family demographics, education levels, cultural trends, shifts in attitudes, and changes in lifestyles.
- Technological factors: This examines changes in digital or mobile technology, automation, and research and development in the relevant industry.
- Legal factors: This entails analyzing employment legislation, consumer law, health and safety regulations, as well as international trade regulations and restrictions.
- Environmental factors: This dimension considers aspects such as climate change, recycling procedures, carbon footprint, waste disposal, and sustainability practices.
Request Full Report – https://reportocean.com/industry-verticals/sample-request?report_id=bw5126
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Email:sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1888 212 3539 (US – TOLL FREE)
Website:https://reportocean.com